1,953
Views
8
CrossRef citations to date
0
Altmetric
Patient Preference

A discrete choice experiment to assess patients’ preferences for HIV treatment in the urban population in Colombia

, ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 812-818 | Received 28 Aug 2019, Accepted 14 Feb 2020, Published online: 06 Apr 2020

References

  • World Health Organisation. Number of people (all ages) living with HIV Estimates by WHO region 2017. Available from: http://apps.who.int/gho/data/view.main.22100WHO?lang=en
  • UNAIDS. UNAIDS data 2017. 2017.
  • Case KK, Ghys PD, Gouws E, et al. Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bull World Health Org. 2012;90:831–838A.
  • Dybul M, Fauci AS, Bartlett JG, et al. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents: the panel on clinical practices for treatment of HIV. Ann Intern Med. 2002;137:381–433.
  • Grierson J, Koelmeyer R, Smith A, et al. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV‐positive Australians. HIV Med. 2011;12:562–569.
  • Lancsar E. Deriving welfare measures from stated preference discrete choice modelling experiments, CHERE Discussion Paper No. 48. 2002.
  • Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14:403–413.
  • Eldredge LKB, Markham CM, Ruiter RA, et al. Planning health promotion programs: an intervention mapping approach. Hoboken (NJ): John Wiley & Sons; 2016.
  • Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making. Pharmacoeconomics. 2008;26:661–677.
  • Ryan M, Gerard K, Amaya-Amaya M. Discrete choice experiments in a nutshell. Using discrete choice experiments to value health and health care. Dordrecht: Springer; 2008. p. 13–46.
  • Mühlbacher AC, Stoll M, Mahlich J, et al. Evaluating the concordance of physician judgments and patient preferences on AIDS/HIV therapy-a Discrete Choice Experiment. Health Econ Rev. 2013;3:30.
  • Terris-Prestholt F, Hanson K, MacPhail C, et al. How much demand for new HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa. PLoS One. 2013;8:e83193.
  • Hendriks A, Wijnen B, van Engelen R, et al. A best-worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment. The Netherlands:Maastricht University; 2016.
  • Brégigeon-Ronot S, Cheret A, Cabié A, et al. Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France. Patient Prefer Adherence. 2017;11:1159–1169.
  • Quaife M, Eakle R, Cabrera M, et al. Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment. BMJ Open. 2016;6:e010682.
  • Gazzard B, Ali S, Muhlbacher A, et al. Patient preferences for characteristics of antiretroviral therapies: results from 5 European countries. J Int AIDS Soc. 2014;17:19540.
  • Safarnejad A, Pavlova M, Son VH, et al. Criteria for prioritization of HIV programs in Viet Nam: a discrete choice experiment. BMC Health Serv Res. 2017;17:719.
  • Hendriks A, Wijnen B, van Engelen R, et al. A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment. J Med Econ. 2018;21:468–473.
  • Veldwijk J, Lambooij MS, de Bekker-Grob EW, et al. The effect of including an opt-out option in discrete choice experiments. PLoS One. 2014;9:e111805.
  • Qualtrics I. Qualtrics. com. Provo (UT); 2013.
  • Tervonen T, Schmidt-Ott T, Marsh K, et al. Assessing rationality in discrete-choice experiments in health: an investigation into the use of dominance tests. Value Health. 2018;21:1192–1197.
  • Hauber AB, Mohamed AF, Watson ME, et al. Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments. AIDS Patient Care STDs. 2009;23:29–34.
  • Cohen MS, Gay C, Kashuba AD, et al. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1 antiretroviral therapy for preventing the sexual transmission of HIV-1. Ann Intern Med. 2007;146:591–601.
  • Stewart M, Brown JB, Donner A, et al. The impact of patient-centered care on outcomes. J Fam Pract. 2000;49:796–804.
  • The World Factbook [Internet]. United States. 2018. Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/co.html